Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Ozempics website notes that it "acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor, the target for native GLP-1." The medication also lowers fasting blood glucose by stimulating insulin secretion, according to Ozempics website
Semaglutide is the active ingredient in both Ozempic (approved for type 2 diabetes management) and Wegovy (approved for chronic weight management)
Retatrutide has been referenced in scientific literature for its interaction with GLP-1, GIP, and glucagon receptor pathways, which are associated with complex endocrine communication and metabolic signaling systems
Hepatology 2010;51:1584-1592
US$ 20.09
US$ 27.98
US$ 29.84
US$ 21.50
US$ 27.69
US$ 24.03
US$ 21.00
US$ 20.83
US$ 21.18
US$ 27.35
